Original Article

Vol. 21 No. 3 (2012): Turkish Journal of Nephrology Türk Nefroloji Derneği Dergisi TND Dergisi

Retrospective Analysis Of End Stage Renal Failure Patients Followed Up In Nephrology Department Between 2005 and 2010

Main Article Content

Salim ÖZENÇ
Mahmut İlker YILMAZ
Murat ÇELİKTEPE
Cengizhan AÇIKEL
Kenan SAĞLAM
Ümit AYDOĞAN

Abstract

OBJECTIVE: End stage renal failure (ESRF) is irreversible impairment of renal functions that

makes surviving impossible without dialysis or renal transplantation. In the present study, we aimed

to put forward the characteristics of end stage renal failure (ESRF) patients who were followed up by

Nephrology Department between 2005 and 2010.

 



MATERIAL and METHODS: This study was carried out through retrospective analysis of the records

of a total of 589 end stage renal failure patients followed up in Department of Nephrology, Gulhane

Military Medical Academy and Military Medical School between 2005 and 2010 and received dialysis

or underwent transplantation.

 



RESULTS: Of the patients in study group, 71.2% (334 patients) were males and 28.8% (135 patients)

were females. The percentage of the patients who had progressed to end stage renal failure was 37.6% in

20-44 age group, and 33% in 65 years and above group. There was a statistically signifi cant difference in

terms of distribution of age groups according to gender (p<0.05). Hypertension was the most common

disease in both gender among ESRF patients (45%) followed by diabetes mellitus (25.4%). Of renal

transplantations, 87 were from live donors and 48 were from cadavers. 48.3% of live donors were

composed of mothers. A total of 88 patients underwent biopsy (65 males and 23 females). FSGS was

the most common histopathologic diagnosis (29.3%)..



CONCLUSION: We put forward 5-year follow up results of our hospital for ESRF, one of the most important public health problems. Studies

should be targeted toward early diagnosis, treatment and slowing progress of renal failure in order to reduce the socioeconomic burden of this

disease in future.


Article Details